Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
affecting patients with cancer and patients with osteoporosis who have been treated with …

Medication-related osteonecrosis of the jaw (MRONJ) has emerged as a complication of anti-
resorptive medications. Despite its low incidence rate, this problem has gained attention in …

Objective To assess the outcomes of several rodent animal models for studying tooth
extraction-related medication-related osteonecrosis of the jaw (MRONJ). Design After a …

Background Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication
associated with antiresorptive medications managing osteoporosis, such as …

Objective The aim of this comprehensive systematic review and meta‐analysis was to
investigate the pathology and pathogenesis of medication‐related osteonecrosis of the jaw …

Objective Previously published animal investigations on bisphosphonate-related
osteonecrosis of the jaws (BRONJ) showed a variety of methods for BRONJ induction and …

Osteonecrosis of the jaws (ONJ), a severe side effect of antiresorptive medications, is
characterized by exposed, nonhealing bone in the oral cavity. Treatment options for ONJ …

The purpose of this study was to investigate the effect of administering intermittent
parathyroid hormone (iPTH) before tooth extraction versus after tooth extraction on the risk of …

Objective Although over a decade has passed since first introduction of BRONJ, the exact
pathophysiology of this disease is still unclear. The present experimental study aimed to …

Introduction Bisphosphonate related osteonecrosis of the jaws (BRONJ) is a recognised
unwanted effect of these drugs which affect bone remodelling. Treatment options range from …